Functional Viability Duck Duck Punch

NCT03053492 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2020-08-03

Study results available
· View outcomes & findings →

Summary

This study has 2 parts: In one part of this study, people with stroke will either play a custom designed computer game for stroke rehabilitation called Duck Duck Punch or an off the shelf computer game with their weaker arm 3 times per week for 6 weeks. Evaluations will determine whether or not one computer game improved arm movement more than the other. In the second part of the study, people with stroke, caregivers of people with stroke and stroke rehabilitation therapists will meet in several focus groups to design a useful and informative Duck Duck Punch performance report.

Conditions

  • Rehabilitation
  • Recovery of Function
  • Stroke

Interventions

DEVICE

Duck Duck Punch Play

The behavioral intervention will include playing a hands-free video game custom designed for stroke survivors.

BEHAVIORAL

Commercially Available Game Play

The behavioral intervention will include playing a hands-free video game available off-the-shelf.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • Medical University of South Carolina

    lead OTHER

Principal Investigators

  • Michelle L Woodbury, PhD · Medical University of South Carolina

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-10
Primary Completion
2019-02-08
Completion
2019-02-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03053492 on ClinicalTrials.gov